Rhythm Biosciences Limited
ASX:RHY.AX
0.062 (AUD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 3.096 | 2.427 | 1.109 | 0.1 | 1.028 | 0 | 0 |
| Cost of Revenue
| 0.199 | 0.189 | 0.101 | 0.147 | 0.141 | 0.065 | 0.032 | 0 |
| Gross Profit
| -0.199 | 2.906 | 2.326 | 0.962 | -0.041 | 0.962 | -0.032 | 0 |
| Gross Profit Ratio
| 0 | 0.939 | 0.958 | 0.868 | -0.413 | 0.936 | 0 | 0 |
| Reseach & Development Expenses
| 2.346 | 3.648 | 5.159 | 4.555 | 1.939 | 0.98 | 0.359 | 0.3 |
| General & Administrative Expenses
| 0 | 7.33 | 5.333 | 2.966 | 1.997 | 2.277 | 1.126 | 0.422 |
| Selling & Marketing Expenses
| 0 | 0.176 | 0.562 | 0.063 | 0.042 | 0.303 | 0.093 | -0.35 |
| SG&A
| 3.004 | 7.506 | 5.895 | 3.028 | 2.039 | 2.58 | 1.219 | 0.072 |
| Other Expenses
| -3.048 | 3.096 | 0.192 | 0.15 | 0.183 | 0.154 | -0.189 | 0 |
| Operating Expenses
| 8.397 | 11.542 | 11.246 | 7.733 | 4.161 | 3.715 | 1.629 | 0.072 |
| Operating Income
| -8.596 | -11.542 | -11.246 | -6.612 | -4.015 | -3.715 | -1.629 | -0.072 |
| Operating Income Ratio
| 0 | -3.728 | -4.633 | -5.965 | -40.152 | -3.615 | 0 | 0 |
| Total Other Income Expenses Net
| 0.049 | 3.096 | 2.452 | -0 | -0.008 | 1.169 | -0.189 | 0 |
| Income Before Tax
| -8.547 | -8.218 | -8.794 | -6.612 | -4.023 | -2.546 | -1.753 | -0.072 |
| Income Before Tax Ratio
| 0 | -2.654 | -3.623 | -5.965 | -40.23 | -2.478 | 0 | 0 |
| Income Tax Expense
| -1.69 | -0.228 | -2.477 | 1.109 | 0.108 | -1.169 | 0.125 | -0.806 |
| Net Income
| -6.857 | -8.218 | -6.316 | -7.721 | -4.131 | -1.377 | -1.753 | -0.072 |
| Net Income Ratio
| 0 | -2.654 | -2.602 | -6.965 | -41.308 | -1.34 | 0 | 0 |
| EPS
| -0.03 | -0.037 | -0.03 | -0.041 | -0.035 | -0.012 | -0.02 | -0.001 |
| EPS Diluted
| -0.03 | -0.037 | -0.03 | -0.041 | -0.035 | -0.012 | -0.02 | -0.001 |
| EBITDA
| -8.397 | -11.352 | -11.144 | -6.465 | -3.874 | -3.649 | -1.597 | -0.072 |
| EBITDA Ratio
| 0 | -3.667 | -4.591 | -5.832 | -38.739 | -3.551 | 0 | 0 |